WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 62
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 82

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 2'051  1'911  1'750  1'564  1'359  594  477  224 
Births 22  21  20  19  17  12  11 
Surviving infants 22  21  20  18  17  12  10 
Pop. less than 5 years 99  91  86  81  76  55  52  34 
Pop. less than 15 years 279  261  240  226  211  154  135  75 
Female 15-49 years 308  290  270  250  228  119  82  41 

Number of reported case

(Click for retrospective incidence data for Qatar)
Diphtheria
Japanese encephalitis
Measles 160  101  295  112  46  314  392 
Mumps 382  368  151  407  65 
Pertussis 11  18  219 
Polio*
Rubella 20  16  23  14  16 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Qatar)
Vaccine year result method % card seen                                                
BCG 1997  96  FHS   89.4  97  97  99  98  100  97 
DTP1 1997  95  FHS   89.4  94  94  98  98  92 
DTP3 1997  91  FHS   89.4  92  93  97  99  80  82  61 
HepB_BD          95  96  99  94  99 
HepB3 1997  85  FHS   89.4  92  93  97  99  89 
Hib3          92  93  97  99  80 
JapEnc         
MCV 1997  90  FHS   89.4  97  99*  99  100  91  79  26 
MCV2          99*  99*  98  99 
PCV1          99*  99*  99  100 
PCV3          92  98  97  99 
Pol3 1997  88  FHS   89.4  92  93  98  98  91  82  61 
Rota1          90  98  55  59 
Rota_last          80  83  40  41 
Rubella1          97  99  100 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Qatar)
BCG 97  97  99  98  97  99  97 
DTP1 94  94  98  99  97  92  94  82 
DTP3 92  93  97  99  97  80  82  61 
HepB3 92  93  97  99  97  89 
Hib3 92  93  97  99  97  80 
MCV 97  98  99  99  96  91  79  26 
PCV3 92  98  97  99 
Pol3 92  93  98  98  98  91  82  61 
Rota_last 80  83  40  41 

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTaP 4-6 years; Yes
DTaPHib 15 months; Yes
DTaPHibHepIPV 2 months; Yes
HepA 12, 18 months;
HepB birth; Yes
MMR 12, 18 months; Yes
OPV 4, 6, 18 months; 4-6 years; Yes
Pneumo_conj 2, 4, 6, 15 months; Yes
Rotavirus 2, 4 months: Yes
Tdap 13-16 years; Yes
Typhoid Yes food handlers and travellers to endemic areas
Varicella 12 months; 4-6 years Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes    Yes  Yes 
What years does the MYP cover? number 2011-2016  2011-2016  2011-2016  2010-2012    2008-2009   
Nº of districts with microplans that include activities to raise immunization coverage number           35  24 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  Yes  Yes         

System performance

Total number of districts in country number NA         
Nº districts with DTP3 coverage >=80% number          
% of districts with DTP3 coverage >=80% From 0 to 100%       100       
Nº districts with measles (MCV1) coverage >=95% number          
% of districts with MCV1 coverage >=95% From 0 to 100%       100       

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR No  No  No  Yes    Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND No  No  No         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 100      95    100 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.